While the prognosis for elderly patients with primary central nervous system lymphoma (PCNSL) is poor, results from a Dutch, nationwide population-based study show survival benefits associated with primary therapy, especially chemotherapy (CT).
ニュース EANO 2019 ニュース EANO 2019 神経科学領域の主要な国際・国内学会のハイライト
How can primary central nervous system lymphoma best be managed in the elderly?
Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.
No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.